Professional Documents
Culture Documents
Hiv 101
Hiv 101
H I V
Acquired
HIV Transmission
HIV enters the bloodstream through:
Open Cuts
HIV Transmission
Common fluids that are a means of transmission:
Blood Semen Vaginal Secretions Breast Milk
Blood 18,000
Semen 11,000
Saliva 1
Blood Exposure:
Perinatal:
HIV-Infected T-Cell
HIV Virus T-Cell HIV Infected T-Cell New HIV Virus
Window Period
This is the period of time after becoming infected
of exposure
10 percent of cases test positive within three to six
months of exposure
---Illness Stage---
Symptom-free
AIDS Symptoms
---Virus Antibody
Infection Occurs
6 month
~ Years
~ Years
~ Years
~ Years----
<
newborn baby
Allows for risk reduction education to reduce or
HIV Testing
Requires a blood or oral fluid sample
HIV test detects the bodys antibody response to HIV
infection
The test does NOT detect the HIV virus
HIV Testing
Those recently exposed should be retested at least six
months after their last exposure. Screening test (EIA/ELISA) vs. confirmatory test (IFA) EIA/ELISA (Reactive) Repeat EIA/ELISA (Reactive) IFA (Reactive) Positive for HIV
HIV Testing
EIA/ELISA Test
Negative No HIV Exposure Low Risk
NEGATIVE
Positive
HIV Exposure High Risk Repeat ELISA Every 3 months for 1 year Repeat every 6 months for continued High risk behavior
POSITIVE
POSITIVE
END TESTING
NEGATIVE
HIV
+
HIV
AIDS
Once a person is infected they are always infected Medications are available to prolong life but they do
Condoms
Using condoms is not 100 % effective in preventing transmission of sexually transmitted infections including HIV
Condom Use
Should be used consistently and correctly
sexual act begins Should be the responsibility of both partners for the protection of both partners Male and female condoms are available
is managed
Can infect people when they engage in high-risk
behavior
When you have sex with someone, you are having sex with everyone they have had sex with for the last ten years.
C. Everett Koop
Former Surgeon General
present in the mucosa of the genital area due to a sexually transmitted infection
Increase the rate of abnormal cell growth Increase the difficulty in curing reactivated or newly acquired genital ulcers Increase the risk of becoming infected with additional STDs
exposure risk and course of treatment Baseline and follow-up HIV testing Four week course of medication initiated one to two hours after exposure Liver function tests to monitor medication tolerance Exposure precautions practiced
Antiretrovirals should not be used for those with lowrisk transmissions or exposures occurring more than 72 hours after exposure.
patient Provide necessary medical care and counseling Evaluate risk event and factors for exposure Determine elapsed time from exposure Evaluate potential for continuous HIV exposure Obtain informed consent for testing and treatment Evaluate pregnancy status of females Monitor for drug toxicity and acute infection